Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126621682 | 12662168 | 2 | F | 20160907 | 20160817 | 20160914 | EXP | JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-53636NB | BOEHRINGER INGELHEIM | 0.00 | Y | 0.00000 | 20160914 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126621682 | 12662168 | 1 | PS | MICARDIS | TELMISARTAN | 1 | Oral | 20 MG | U | 20850 | 20 | MG | TABLET | QD | |||||
| 126621682 | 12662168 | 2 | C | BAYASPIRIN | ASPIRIN | 1 | Unknown | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126621682 | 12662168 | 1 | Product used for unknown indication |
| 126621682 | 12662168 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126621682 | 12662168 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126621682 | 12662168 | Hospitalisation | |
| 126621682 | 12662168 | Product colour issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |